Kilitch Drugs (India) Limited (IN:KILITCH)
:KILITCH
Total Valuation
Kilitch Drugs (India) Limited has a market cap or net worth of ₹4.86B. The enterprise value is ₹5.35B.
Market Cap₹4.86B
Enterprise Value₹5.35B
Share Statistics
Kilitch Drugs (India) Limited has 34,961,563 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding34,961,563
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kilitch Drugs (India) Limited’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 8.20%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)8.20%
Return on Capital Employed (ROCE)0.12
Revenue Per Employee11.80M
Profits Per Employee2.05M
Employee Count168
Asset Turnover0.63
Inventory Turnover6.83
Valuation Ratios
The current PE Ratio of Kilitch Drugs (India) Limited is 34.5. Kilitch Drugs (India) Limited’s PEG ratio is 0.27.
PE Ratio34.5
PS Ratio2.92
PB Ratio2.86
Price to Fair Value2.86
Price to FCF-19.75
Price to Operating Cash Flow-73.22
PEG Ratio0.27
Income Statement
In the last 12 months, Kilitch Drugs (India) Limited had revenue of 1.98B and earned 267.01M in profits. Earnings per share was 8.12.
Revenue1.98B
Gross Profit937.39M
Operating Income283.55M
Pretax Income344.74M
Net Income267.01M
EBITDA426.26M
Earnings Per Share (EPS)8.12
Cash Flow
In the last 12 months, operating cash flow was -66.20M and capital expenditures -515.03M, giving a free cash flow of -581.23M billion.
Operating Cash Flow-66.20M
Free Cash Flow-581.23M
Free Cash Flow per Share-16.62
Dividends & Yields
Kilitch Drugs (India) Limited pays an annual dividend of ₹0.5, resulting in a dividend yield of ―
Dividend Per Share₹0.5
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.09
52-Week Price Change-18.90%
50-Day Moving Average160.68
200-Day Moving Average184.07
Relative Strength Index (RSI)36.65
Average Volume (3m)2.19K
Important Dates
Kilitch Drugs (India) Limited upcoming earnings date is May 27, 2026, TBA (Confirmed).
Last Earnings DateFeb 11, 2026
Next Earnings DateMay 27, 2026
Ex-Dividend Date―
Financial Position
Kilitch Drugs (India) Limited as a current ratio of 2.06, with Debt / Equity ratio of 31.47%
Current Ratio2.06
Quick Ratio1.88
Debt to Market Cap0.09
Net Debt to EBITDA0.93
Interest Coverage Ratio5.62
Taxes
In the past 12 months, Kilitch Drugs (India) Limited has paid 95.34M in taxes.
Income Tax95.34M
Effective Tax Rate0.28
Enterprise Valuation
Kilitch Drugs (India) Limited EV to EBITDA ratio is 14.52, with an EV/FCF ratio of -21.10.
EV to Sales3.12
EV to EBITDA14.52
EV to Free Cash Flow-21.10
EV to Operating Cash Flow35.27
Balance Sheet
Kilitch Drugs (India) Limited has ₹870.13M in cash and marketable securities with ₹836.13M in debt, giving a net cash position of ₹34.01M billion.
Cash & Marketable Securities₹870.13M
Total Debt₹836.13M
Net Cash₹34.01M
Net Cash Per Share₹0.97
Tangible Book Value Per Share₹50.68
Margins
Gross margin is 43.55%, with operating margin of 14.30%, and net profit margin of 13.46%.
Gross Margin43.55%
Operating Margin14.30%
Pretax Margin17.38%
Net Profit Margin13.46%
EBITDA Margin21.49%
EBIT Margin19.93%
Analyst Forecast
The average price target for Kilitch Drugs (India) Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast32.95%
EPS Growth Forecast67.39%